RSV Immunogenicity Study in the Elderly (RISE) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

RSV Immunogenicity Study in the Elderly (RISE) — Stella

Recruiting

Back to RSV Immunisation trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

Sweden

Familjeläkarna SÄBO, Saltsjöbaden

Akademiskt specialistcentrum Studieenheten, Stockholm

Key details

Phase

Large-scale testing

Sponsor

Karin Karin Loré

Collaborators

Karolinska Institutet

Enrollment target

~65 participants

Started

August 2025

Primary completion

May 2027

Age range

60 Years and older

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov